Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06396962
Status:
COMPLETED
Last Update Posted:
2024-05-02
First Post:
2024-04-29
Brief Title:
Survival and Prognostic Factors of Primary Retroperitoneal Sarcomas After Surgery a Single-center Experience
Sponsor:
Northern Jiangsu Peoples Hospital
Organization:
Northern Jiangsu Peoples Hospital
Study Overview
Official Title:
Survival and Prognostic Factors of Primary Retroperitoneal Sarcomas After Surgery a Single-center Experience
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
he percentage of retroperitoneal sarcomas RPS among all soft tissue sarcomas ranges from 10-15 Surgery remains the gold standard for RPS In this study we analyzed the impact of surgical treatment for primary RPS on recurrence and overall mortality at a Chinese institution and identified and evaluated prognostic variables
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None